Compare · 3 funds side by side · dividends reinvested

PCR, VCSH and VCIT

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$11,379VCSH · best of the three

02 / 04

PCR, VCSH and VCIT, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Short-Term Corporate Bond ETFBonds & Cash · Corporate0.03%4.54%+1.4%+2.3%+5.8%+2.6%−1.6%2.1%$43.9B1.4

Vanguard Intermediate-Term Corporate Bond ETFBonds & Cash · Corporate0.03%5.02%−0.6%+0.3%+7.3%+1.0%−4.9%4.5%$66.6B1.8

Simplify VettaFi Private Credit Strategy ETFBonds & Cash · Corporate0.76%12.49%−15.4%−17.7%[…][…]−19.4%16.9%$2M2.7

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: PCR 2025 · VCSH 2009 · VCIT 2009

Head to Head

Swap sides Versus in desk

Head to Head

Simplify VettaFi Private Credit Strategy ETF · $2M[…]

PCR

VCSH

Vanguard Short-Term Corporate Bond ETF · $43.9B$11,379

$10,000 five years ago, dividends reinvested

PCRMeasureVCSH

−15.4%Year to dateJan 1 → Nov 5+1.4%

−17.7%1 yearTotal return+2.3%

[…]3 years · per year$10,000 became […] · $11,843+5.8%

[…]5 years · per year$10,000 became […] · $11,379+2.6%

0.76%Expense ratio$76 · $3 a year on $10k · lower is better0.03%

12.49%Trailing 12-mo yield$1,249 · $454 a year on $10k4.54%

−19.4%Worst dropSmaller is better−1.6%

16.9%VolatilityLower is calmer2.1%

PCRVCSH Winner of the row, in its colourEach row: the bigger of the two fills its side

1–5VCSH wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PCR vs VCSH: Top 5 Holdings

Today

PCR

[…]in top 5

VCSH

in top 5[…]

Holdings […] not in today’s data

Held in common[…]

End-of-day Nov 5, 2026 · share of each fund

PCR vs VCSH Returns, Every Period

SimplifyPCR

−17.7%

past year

VCSHVanguard

+2.3%

past year

PCRVCSHFaded: behind in that period

0–2VCSH wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

PCR vs VCIT

YTD

SimplifyPCR

−15.4%

VCITVanguard

−0.6%

−15.4%Year to date−0.6%

−19.4%Worst drop · 1Y−4.9%

16.9%Volatility · 1Y4.5%

12.5%Yield5.0%

$2.2MAssets$66.6B

3–1VCIT wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PCR, VCSH, VCIT

Today

0.03%lowest, VCSH

FundExpense ratioFee$10k

VCSH0.03%$3

VCIT0.03%$3

PCR0.76%$76

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: PCR, VCSH, VCIT

12.49%highest, PCR

FundTrailing yieldYield$10k

PCR12.49%$1,249

VCIT5.02%$502

VCSH4.54%$454

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$1,173most kept, PCR

PCR$1,249 − $76 = $1,173

VCIT$502 − $3 = $499

VCSH$454 − $3 = $451

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: PCR, VCSH, VCIT

Today

[…]holdings […]

PCRVCSHVCIT

PCR—[…][…]

VCSH[…]—[…]

VCIT[…][…]—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+2.3%VCSH, at 2.1% volatility

VCSHWorst drop−1.6%2.1% vol

VCITWorst drop−4.9%4.5% vol

PCRWorst drop−19.4%16.9% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

PCRVCSH

−15.4%Year to date+1.4%

12.5%Yield4.5%

−17.7%Past year+2.3%

0.76%Fee0.03%

3–1VCSH wins

End-of-day Nov 5, 2026

Popular Pairs Near These Three

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.6BAssets$46.8B

2–0JEPQ wins

End-of-day Nov 5, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.4%

SPYSPDR

+8.3%

+8.4%Year to date+8.3%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 5, 2026